|
⚲
|
| Keyboard |
| Morgenthaler Management Partners IX LLC
✚
|
|
|---|---|
| CIK # | 0001666860 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001666860] | |
| 3 | [0001666860] | |
| 4 | [0001666860] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Doximity Inc | |
| Morgenthaler Venture Partners IX LP | |
| Morgenthaler Management Partners IX LLC | |
| Vapotherm Inc | |
| Principia Biopharma Inc | |
| Ra Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Doximity Inc DOCS
Class A Common Stock
|
2021-11-12 | Other | 8,535,175 | $0.00 | |
|
Doximity Inc DOCS
Class B Common Stock · derivative
|
2021-11-10 | Conversion | 17,070,350 | $0.00 | |
|
Doximity Inc DOCS
Class A Common Stock
|
2021-11-10 | Conversion | 17,070,350 | $0.00 | |
|
Doximity Inc DOCS
Series C Preferred Stock · derivative
|
2021-06-28 | Conversion | 1,659,476 | $0.00 | |
|
Doximity Inc DOCS
Series B Preferred Stock · derivative
|
2021-06-28 | Conversion | 15,410,874 | $0.00 | |
|
Doximity Inc DOCS
Class B Common Stock · derivative
|
2021-06-28 | Conversion | 17,070,350 | $0.00 | |
|
Vapotherm Inc VAPO
Series C Convertible Preferred Stock · derivative
|
2018-11-16 | Conversion | 359,842 | $0.00 | |
|
Vapotherm Inc VAPO
Common Stock
|
2018-11-16 | Conversion | 921,348 | ||
|
Vapotherm Inc VAPO
Common Stock
|
2018-11-16 | Conversion | 61,342 | ||
|
Vapotherm Inc VAPO
Series A Convertible Preferred Stock · derivative
|
2018-11-16 | Conversion | 214,285 | $0.00 | |
|
Vapotherm Inc VAPO
Series B Convertible Preferred Stock · derivative
|
2018-11-16 | Conversion | 217,803 | $0.00 | |
|
Vapotherm Inc VAPO
Series D-1 Convertible Preferred Stock · derivative
|
2018-11-16 | Conversion | 61,342 | $0.00 | |
|
Vapotherm Inc VAPO
Series D Convertible Preferred Stock · derivative
|
2018-11-16 | Conversion | 129,418 | $0.00 | |
|
Ra Pharmaceuticals Inc RARX
Warrants to Purchase Common Stock · derivative
|
2016-10-31 | Option exercise | 63,019 | $0.00 | |
|
Ra Pharmaceuticals Inc RARX
Series B-2 Preferred Stock · derivative
|
2016-10-31 | Conversion | 3,408,439 | ||
|
Ra Pharmaceuticals Inc RARX
Series A Preferred Stock · derivative
|
2016-10-31 | Conversion | 9,744,916 | ||
|
Ra Pharmaceuticals Inc RARX
Series B-1 Preferred Stock · derivative
|
2016-10-31 | Conversion | 3,664,071 | ||
|
Ra Pharmaceuticals Inc RARX
Common Stock
|
2016-10-31 | Buy | 263,538 | $13.00 | 3,425,994 |
|
Ra Pharmaceuticals Inc RARX
Common Stock
|
2016-10-31 | Option exercise | 63,019 | $0.07 | 4,411 |
|
Ra Pharmaceuticals Inc RARX
Common Stock
|
2016-10-31 | Sell | 340 | $13.00 | 4,420 |
| showing 20 of 23 most recent transactions | |||||